Data taken from [36]. Polymyalgia rheumatica (PMR) is the second most common autoimmune rheumatic disorder; giant cell arteritis (GCA) is the most frequent vasculitis in the elderly. PMR patients ...

Patients with predominantly cranial vs isolated extracranial GCA phenotypes present with different patterns of arterial involvement on 18F-FDG PET-CT scans.

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

1 Clinical Investigation Centre Biotherapy INSERM CIC-1431, University Hospital of Besançon, Besançon, France 2 Fédération Hospitalo-Universitaire INCREASE, University Hospital of Besançon, Besançon, ...

Good morning and good afternoon, and welcome to the Novartis Q4 2024 results release conference call and live webcast. [Operator instructions] The conf ...

And over the course of year, we expect two Phase 3 readouts in giant cell arteritis and polymyalgia rheumatica which, if positive, would provide further engines for growth for Cosentyx through the ...

Polymyalgia rheumatica (PMR) is considered to be a benign disease by some, while others think it is a more serious illness which required similar treatment to giant cell arteritis (GCA). The progress ...

Objectives To determine whether whole-body MRI defines clinically relevant subgroups within polymyalgia rheumatica (PMR ... with extracapsular pattern later developed biopsy-proven giant cell ...

Giant cell arteritis (GCA) is a chronic systemic vasculitis affecting ... This previously reported 67-year-old woman with refractory PMR since 2003, presented in 2010 with worsening proximal pain and ...